LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1Catalyst Biosciences
03 1Insmed
04 6Ipsen
05 1Recordati Rare Diseases
Reset all filters
01 1Eye Drop Solution
02 2INJECTABLE;SUBCUTANEOUS
03 2Injectable Solution
04 1Mecasermina 40Mg 4Ml 1 Units Parenteral Use
05 1SOLUTION
06 2TABLET;ORAL
07 1Blank
Reset all filters
01 1Approved
02 2Authorized
03 1DISCN
04 1Prescription
05 1RX
06 4Blank
Reset all filters
01 1Cystadrops
02 2INCRELEX
03 1INVERSINE
04 1IPLEX
05 4Increlex
06 1MECAMYLAMINE HYDROCHLORIDE
Reset all filters
01 1Australia
02 1Canada
03 1Italy
04 2Spain
05 1Sweden
06 4USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
Brand Name : MECAMYLAMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2013-03-19
Application Number : 204054
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : INVERSINE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 10251
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
MECASERMIN RINFABATE RECOMBINANT
Brand Name : IPLEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 36MG/0.6ML
Packaging :
Approval Date :
Application Number : 21884
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : INCRELEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/4ML (10MG/ML)
Packaging :
Approval Date :
Application Number : 21839
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Increlex
Dosage Form : Mecasermina 40Mg 4Ml 1 Units Parenteral Use
Dosage Strength : 1 vial SC 4 ml 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Increlex
Dosage Form : Injectable Solution
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 03/08/2007
Application Number : 20060209000014
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : INCRELEX
Dosage Form : SOLUTION
Dosage Strength : 40MG/4ML
Packaging :
Approval Date :
Application Number : 2509733
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Increlex
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Authorized
Registration Country : Spain
Water For Injectable Preparations; Mecasermin
Brand Name : Increlex
Dosage Form : Injectable Solution
Dosage Strength : 10MG
Packaging :
Approval Date : 2007-09-25
Application Number : 07402001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Cystadrops
Dosage Form : Eye Drop Solution
Dosage Strength : 3.8MG
Packaging :
Approval Date : 2017-12-27
Application Number : 1151049001
Regulatory Info : Authorized
Registration Country : Spain